← Back to Search

Behavioural Intervention

PEAR-008 for Opioid Use Disorder

N/A
Waitlist Available
Research Sponsored by Pear Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Provide informed consent prior to any study specific assessments being performed
Between 18 and 60 years old, inclusively
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up)
Awards & highlights

Study Summary

This trial will help researchers understand if a game-based mobile app can help people with opioid use disorder.

Eligible Conditions
  • Opioid Use Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8 (end of treatment), week 12 (follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate Participant Engagement Data
Secondary outcome measures
Assess Coronavirus Disease (COVID-19) Impact
Assess Coronavirus Disease (COVID-19) Impact on Stress
Anxiety
+8 more
Other outcome measures
Change in Skill Acquisition
Evaluate Engagement and Efficacy Relationship
Medication Adherence Rates

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PEAR-008Experimental Treatment1 Intervention
Investigational Digital Therapeutic
Group II: reSET-OActive Control1 Intervention
Prescription Digital therapeutic
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PEAR-008
2021
N/A
~60

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,447 Previous Clinical Trials
2,594,014 Total Patients Enrolled
Pear Therapeutics, Inc.Lead Sponsor
5 Previous Clinical Trials
1,865 Total Patients Enrolled
Addiction Research and Education Foundation (AREF)UNKNOWN

Frequently Asked Questions

~14 spots leftby Mar 2025